Additionally, as many as two out of three people on GLP-1s stop within a year and quickly regain the weight they lost, underscoring the need for an effective medication-free alternative and off-ramp from the medications to achieve sustainable results
The lawsuit claims Novo Nordisk failed to provide adequate warnings about the risk of gastroparesis and other adverse events allegedly associated with Ozempic, including gastrointestinal injuries, ischemic bowel, necrotizing pancreatitis, gallbladder disease, deep vein thrombosis, micronutrient deficiencies, Wernickes encephalopathy and aspiration of gastric contents
5, Fu Shin St., Kuei-Shan, Taoyuan 333, Taiwan E-mail: [email protected] Copyright 2023 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
The distinction is critical for those navigating the landscape of hormone production